Seattle biotech firm Shape Therapeutics inks gene therapy deal

Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s

AllStripes raises $50M, Shape-Roche's Dela

Biomolecules, Free Full-Text

PHL Inno - Lab Notes: National Disease Research Interchange

Seattle biotech firm Shape Therapeutics inks gene therapy deal

Shape Therapeutics Inc.

White House cybersecurity summit to include 's Andy Jassy, Microsoft's Satya Nadella – GeekWire

The Global Pricing of Approved Cell Therapy Products

Scribe Therapeutics, Eli Lillly gene therapy unit Prevail ink potential

Fierce Biotech's 2022 Fierce 15